SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-052107
Filing Date
2023-04-28
Accepted
2023-04-28 08:00:07
Documents
4
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2312833d3_def14a.htm DEF 14A 279036
2 GRAPHIC tm2312833d3_def14aimg001.jpg GRAPHIC 17985
3 GRAPHIC tm2312833d3_def14aimg002.jpg GRAPHIC 149247
4 GRAPHIC tm2312833d3_def14aimg003.jpg GRAPHIC 203416
  Complete submission text file 0001104659-23-052107.txt   790991
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

IRS No.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39202 | Film No.: 23860247
SIC: 2834 Pharmaceutical Preparations